## STZ: Constellation Brands, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.5% below STRENGTH zone (4.0-10.0%); PEG 1.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($135.33)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Generali Asset Management SPA SGR Makes New Investment in Carlyle Group Inc. $CG**
- Source: MarketBeat | 20260104T110849 | Neutral | Relevance: 62%
- Generali Asset Management SPA SGR has acquired a significant new stake of 30,518 shares in Carlyle Group Inc. during Q3, valued at approximately $1.913 million. This new investment is part of broader institutional activity in Carlyle Group, which includes substantial holdings from Norges Bank and Vanguard Group Inc. The company currently holds a "Hold" consensus rating from analysts with a price target of $66.62, while insiders own 26.30% of the stock.

**2. From Bilibili creator to robot helmsman, can Zhihuijun's Qiyuan Q1 reshape the personal-robot market?**
- Source: Gasgoo | 20260104T213700 | Neutral | Relevance: 61%
- Peng Zhihui, known as "Zhihuijun" on Bilibili, has launched the Qiyuan Q1, a small-sized humanoid robot under his brand "Shangwei Qiyuan," targeting the personal-robot market. The Qiyuan Q1, standing 0.8 meters tall, features full-body force control and an open-source approach, reflecting Peng's "hardcore engineering" and "mass communication" ethos. This move tests whether a tech influencer can successfully transition into entrepreneurship and bring advanced robotics into everyday consumer use, with 2025 seen as a pivotal year for scaled humanoid production.

**3. Canopy Growth (NASDAQ:CGC) Director Sells $11,790.42 in Stock**
- Source: MarketBeat | 20260103T000823 | Neutral | Relevance: 60%
- Canopy Growth Director Theresa Yanofsky sold 10,434 shares worth $11,790.42 on December 31st, reducing her stake by 14.11%. The cannabis company's stock trades around $1.19 with a market cap of $438 million, and analysts currently rate it as "Reduce" despite an EPS beat but revenue miss in its last quarterly report.

**4. Budweiser (US) Review: Why America’s Most Famous Beer Still Starts the Party**
- Source: AD HOC NEWS | 20260104T070826 | Neutral | Relevance: 60%
- This article reviews Budweiser (US), highlighting its role as a classic American lager that offers consistency, tradition, and uncomplicated drinkability. It details the ingredients and brewing process that contribute to its crisp, refreshing, and widely appealing taste. The review positions Budweiser as a reliable choice for social gatherings, contrasting it with more complex craft beers and discussing its target audience.

**5. Top S&P 500 Index, SPY, and VOO ETF news to watch this week**
- Source: TradingView — Track All Markets | 20260105T130859 | Neutral | Relevance: 60%
- This article outlines key market drivers for the S&P 500 Index, SPY, and VOO ETFs this week, including the limited impact of US actions in Venezuela. Investors should focus on upcoming US manufacturing and services PMI reports, non-farm payrolls data, and initial earnings reports from several large American companies. These factors will influence Federal Reserve decisions and overall market sentiment.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Wells Fargo | $160 | $155 | +3% |
| 2025-12-17 | Jefferies | $154 | $170 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Wells Fargo | main | Overweight |
| 2025-12-17 | Jefferies | down | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.5% (+3.2%)
- Berkshire Hathaway, : 7.7% (0.0%)
- Blackrock Inc.: 6.1% (-2.0%)
- Capital World Invest: 3.8% (-43.3%)
- State Street Corpora: 3.8% (-4.2%)

### Key Risks

1. Long-term trend broken: trading 10.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $24.8B |
| Beta | 0.44 |
| 52W Range | $126.45 - $228.89 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 11.5 |
| Current P/E | 12.4 |
| YoY Growth | 7.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.2% to 0.5% (+2.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.5pp (needs >4.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 56. OFD pattern: +DUH (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.51% (CS: 48) | Neutral |
| RSI_14 | 55.8 | Neutral |
| MACD Histogram | -0.20 | Bearish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 0.896x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $142.51
- **Stop Loss:** $135.33 (5.0% risk)
- **Target:** $149.69 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 80
- **Position Value:** $11,400.80
- **Portfolio %:** 11.40%
- **Risk Dollars:** $575.00
- **Risk Per Trade:** 0.57%
- **Modifiers:** L1 115% | L2 50% | Combined 0.57x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-07 (Est: $2.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.41 | $3.63 | +6.5% |
| 2025Q2 | $3.29 | $3.22 | -2.3% |
| 2025Q1 | $2.27 | $2.63 | +15.9% |
| 2024Q4 | $3.31 | $3.25 | -1.9% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*